Radiogenomics in Active Surveillance How Can We Integrate mpMRI and Genomics to Monitor PCa

Sanoj Punnen, MD, MAS, discusses the limitations of multiparametric MRI (mpMRI) and genomic biomarkers in selecting men with intermediate or high-risk prostate cancer for active surveillance. He suggests that combining mpMRI and genomics may allow for more accurate risk-stratification, focusing on preliminary data from the Miami MAST trial. Read more here: https://grandroundsinurology.com/radi...